文献速递胸部肿瘤放疗放疗物理与技术

单等中心与多等中心治疗多发性肺转移瘤:肺剂量评估

Single-isocenter versus multiple-isocenters for multiple lung metastases: Evaluation of lung dose.
PubMed 文献 · Radiother Oncol · 2021-12-02

本研究对15例既往接受过立体定向体部放疗(SBRT)的NSCLC患者(每例2或3个病灶)分别按多等中心技术和单等中心技术制定治疗计划,单等中心又评估两种外扩边界策略,共45个计划,比较平均肺剂量(MLD)和肺V20Gy。结果显示单等中心计划MLD中位升高11.6%,V20Gy升高0.2个百分点,作者认为正常肺剂量的增加在临床上可接受。

要点

  • 单等中心技术MLD为5.4±2.1 Gy(方法1)和5.3±2.2 Gy(方法2),多等中心为4.9±1.9 Gy。
  • 单等中心对比多等中心,MLD中位升高11.6%(范围-14.9至26.8)。
  • V20Gy在多等中心为5.5±3.7%,单等中心方法1和方法2分别为5.5±3.2%和5.4±3.3%。

核心结论

  • 作者结论认为,对多靶点肺患者采用单等中心SBRT技术,正常肺剂量的增加在临床上可接受。

研究设计与样本

  • 研究纳入15例既往接受过SBRT的NSCLC患者,每例有2或3个病灶。
  • 对每例患者分别按多等中心技术和单等中心技术制定治疗计划,单等中心评估两种外扩边界策略,共45个治疗计划。
  • 单等中心方法1为每个内靶区(ITV)采用相同外扩边界,假设锥形束CT(CBCT)定位验证时对所有病灶进行平均配准。
  • 单等中心方法2为最大病灶采用较小外扩边界,假设对该病灶进行最优配准。
  • 研究按照RATING指南实施。

主要发现

  • MLD(均值±标准差)在多等中心为4.9±1.9 Gy,单等中心方法1为5.4±2.1 Gy,方法2为5.3±2.2 Gy。
  • V20Gy在多等中心为5.5±3.7%,单等中心方法1为5.5±3.2%,方法2为5.4±3.3%。
  • 单等中心治疗计划对比多等中心计划,MLD中位升高11.6%(范围-14.9至26.8)。
  • 单等中心治疗计划对比多等中心计划,V20Gy升高0.2个百分点(范围-3.4至1.3)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A potential challenge in single-isocenter multi-lesion lung stereotactic body radiotherapy (SBRT) is that patient positioning is not based on each lesion individually, but on the average position of all lesions. This may lead to larger margins compared to treating with one isocenter per lesion, but increases workflow efficiency. The aim of this study was to investigate whether a single-isocenter technique leads to increased normal lung dose compared to a conventional multiple-isocenters technique. MATERIALS AND METHODS: A cohort of 15 NSCLC patients with two or three lesions previously treated with SBRT was subjected to treatment planning with a multiple-isocenter technique and a single-isocenter technique. For the latter, two margin approaches were evaluated: (1) identical margins for each internal target volume (ITV), assuming an average registration for all lesions in cone-beam CT (CBCT) positioning verification and (2) a smaller margin for the largest lesion, assuming an optimal registration for that lesion. For all 45 treatment plans, mean lung dose (MLD) and lungs-V20Gy were evaluated. The study was performed following RATING guidelines. RESULTS: The MLD was 4.9 ± 1.9 Gy (mean ± SD) for multiple-isocenters and 5.4 ± 2.1 Gy and 5.3 ± 2.2 Gy for single-isocenter approach 1 and 2, respectively. V20Gy was 5.5 ± 3.7%, 5.5 ± 3.2% and 5.4 ± 3.3%. A median [range] increase in MLD of 11.6% [-14.9 - 26.8] was observed when comparing single-isocenter treatment plans to those with multiple isocenters. V20Gy increased by 0.2 [-3.4 - 1.3] percentage points. CONCLUSION: A single-isocenter SBRT technique for lung patients with multiple targets results in clinically acceptable increases in normal lung dose.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. van Timmeren JE, Ehrbar S, Chamberlain M, et al. Single-isocenter versus multiple-isocenters for multiple lung metastases: Evaluation of lung dose. Radiother Oncol. 2021. PMID: 34864135. doi:10.1016/j.radonc.2021.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。